4//SEC Filing
Manning Linda Shapiro 4
Accession 0001104659-21-116017
CIK 0001649904other
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 6:51 PM ET
Size
8.2 KB
Accession
0001104659-21-116017
Insider Transaction Report
Form 4
Manning Linda Shapiro
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-09-10+15,000→ 15,000 totalExercise: $12.98Exp: 2031-09-09→ Common Stock (15,000 underlying) - Award
Restricted Stock Units
2021-09-10+2,500→ 2,500 total→ Common Stock (2,500 underlying)
Footnotes (3)
- [F1]The stock options were granted on September 10, 2021. 25% of the shares subject to the option will vest and become exercisable on September 10, 2022 and the remaining 75% of the shares subject to the option shall vest and become exercisable in 12 substantially equal installments upon the Reporting Person's completion of each three full months of successive service to the Issuer thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- [F3]The restricted stock units vest as to 25% of the total shares on each of September 10, 2022, September 10, 2023, September 10, 2024 and September 10, 2025. The restricted stock units have no expiration date.
Documents
Issuer
RHYTHM PHARMACEUTICALS, INC.
CIK 0001649904
Entity typeother
Related Parties
1- filerCIK 0001883256
Filing Metadata
- Form type
- 4
- Filed
- Sep 14, 8:00 PM ET
- Accepted
- Sep 15, 6:51 PM ET
- Size
- 8.2 KB